Francesca Pisano's practice focuses on assisting clients with complex civil antitrust litigation, government review of mergers and acquisitions, filing obligations under the Hart-Scott-Rodino Act, and counseling clients in relation to antitrust issues. Ms. Pisano has represented clients in a variety of industries including financial services, industrial equipment, medical devices, telecommunications, and consumer products.

Ms. Pisano graduated with high honors from Emory Law School in 2013, where she served as a Notes and Comments Editor for the Emory Law Journal. Upon graduating from law school, she was elected to the Order of the Coif and awarded the Pro Bono Publico medal for her pro bono service. During law school, Ms. Pisano served as a legal intern in the Ethics & Compliance Office of a Fortune 100 company.


  • AT&T Inc. in connection with its successful $85.4 billion stock-and-cash acquisition of Time Warner Inc., including the DOJ's litigation challenging the transaction.
  • Broadcast television company in connection with a Department of Justice and State Attorney General investigation into alleged exclusionary conduct. The investigation was closed without any action taken against the company.
  • Monsanto in connection with the proposed sale of Precision Planting to Deere & Company, including the DOJ's litigation challenging the transaction.
  • General Electric in its acquisitions of Arcam AB and Concept Laser GmbH, two additive manufacturing companies.
  • General Electric in connection with the proposed sale of its appliances business to AB Electrolux, including the DOJ's litigation challenging the transaction.
  • General Electric in connection with the $5.6 billion sale of its appliances business to Qingdao Haier Co., Ltd.
  • Fortune 50 company on issues related to Clayton Act § 8 (interlocking directorates).
  • TPG Capital, a private equity firm, in connection with private civil antitrust litigation in the District of Massachusetts regarding leveraged buyout bidding practices of leading private equity firms.
  • Pharmaceutical Research and Manufacturers America (PhRMA), as amicus curiae in In re Lamictal Antitrust Litigation (3rd Cir.), in an appeal concerning the application of antitrust laws to pharmaceutical patent litigation settlements following the Supreme Court's decision in FTC v. Actavis (2013).
  • Yamashita Rubber Co. Ltd. in complex multi-district antitrust litigation alleging bid rigging and price fixing of anti-vibration rubber parts arising out of the government's investigation into the auto parts industry.


2018 US Merger Enforcement Year in Review
FTC Approves Corpus Christi Polymers Joint Venture with Conduct Remedies
Using the Distribution Agreement to Reduce Robinson-Patman Litigation Risk
Antitrust Considerations For Government Contractors
Aerospace & Defense Law360, Competition Law360, Employment Law360, Government Contracts Law360, Health Law360, Mergers & Acquisitions Law360
Why FTC Accepted Conduct Remedies In Northrop Deal
Aerospace & Defense Law360, Competition Law360, Mergers & Acquisitions Law360, Technology Law360


  • JD, Emory University School of Law, 2013, with high honors, Order of the Coif
  • BA, George Washington University, 2009, cum laude
  • District of Columbia
  • Massachusetts
  • US District Court, District of Massachusetts

Email Disclaimer